Glen Michael Fitzpatrick is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of medical innovations, particularly in the area of antiplatelet therapy. With a total of six patents to his name, Fitzpatrick's work is paving the way for advancements in treating coagulopathy.

Latest Patents

Fitzpatrick's latest patents include innovative methods for treating bleeding in subjects who have been treated with antiplatelet agents. One of his notable inventions is titled "Thrombosomes as an antiplatelet agent reversal agent." This method involves administering an effective amount of a composition that includes platelets or platelet derivatives along with an incubating agent. The composition may also contain one or more salts, a buffer, and optionally a cryoprotectant or an organic solvent. This invention aims to provide a solution for subjects experiencing coagulopathy due to antiplatelet treatment.

Career Highlights

Fitzpatrick is currently associated with Cellphire, Inc., a company that focuses on developing innovative solutions in the field of blood products. His work at Cellphire has been instrumental in advancing the understanding and treatment of bleeding disorders.

Collaborations

Fitzpatrick has collaborated with several professionals in his field, including Braden Carl Ishler and Keith Andrew Moskowitz. These collaborations have contributed to the development of his innovative patents and have enhanced the research efforts at Cellphire.

Conclusion

Glen Michael Fitzpatrick is a prominent inventor whose work in antiplatelet therapy is making a significant impact in the medical field. His innovative patents and collaborations are paving the way for new treatments that could improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.